A supernumerary minichromosome has been detected in a severely malformed patient. Attempts at identifying the marker by conventional approaches were unsuccessful. The physical isolation of the minichromosome by fluorescence activated sorting, molecular cloning of its DNA, and in situ hybridisation experiments performed with single copy DNA probes allowed us to show that it was derived from a rearrangement involving the centromere and the proximal region of the short arm of chromosome 9.
A distinct class of abnormal chromosomes which may pose problems of identification is represented by the so-called 'minichromosomes' or 'microchromosomes'. These are chromosomes sized from one-third to one-fifth of the G group elements, usually added to a normal complement. Their pathological significance is uncertain and generally variable, since the associated symptoms may range from severe to almost normal clinical conditions45; mosaics are very frequent. In some cases the pathological traits associated with the presence of a minichromosome may serve for the selection of appropriate molecular probes localised to specific chromosomal regions.'
The stability of a minichromosome probably depends on the integrity of the centromeric and telomeric sequences. In most cases these components are expected to be functionally normal, because minichromosomes are maintained in successive cell generations.
We have observed a minichromosome (MC) in a patient with multiple malformations. Conventional chromosome analysis failed to establish the origin of the marker. For the identification of the MC several approaches have been used, based on either standard cytogenetic analyses with various banding techniques or in situ hybridisation with probes recognising centromeres or nucleolar organising regions. As none of these methods allowed us to classify the marker chromosome, we tried a direct approach based on the physical isolation of the MC by fluorescence activated sorting and on the construction of a genomic library.
By means of in situ hybridisation with low copy number probes derived from the MC library, we have been able to identify the MC as a product of a rearrangement of chromosome 9.
Case report
The proband, a female, was born by normal delivery at 38 weeks of gestation after a pregnancy complicated by minor problems, including allergic rhinitis, recurrent headache, and, during the last weeks, moderate hypertension. Fetal movements were felt Origin ofa hunan minichromosome at 15 weeks of gestation, but decreased fetal activity was noted after the sixth month. Birth weight was 1600 g (<3rd centile), she was 43 cm long (<3rd centile), with a head circumference of 29-8 cm (<3rd centile). Apgar score at one and five minutes was 10. She was admitted to a neonatal pathology department, where physical examination showed marked dysmorphic features including a narrow forehead and a large, hooked nose; the eyes were apparently normal and there was marked micrognathia. The nipples were hypoplastic. The right lower limb was hypotrophic with a reduced diameter (1 5 cm at all levels); however, the length was equal to the left leg. Bilateral hammer toe was present with short halluces. The limbs were kept flexed and adducted and spontaneous movement was markedly reduced. Dorsal hyperflexion of the metacarpophalangeal and metatarsophalangeal joints associated with phalangeal flexion was present; complete extension of the elbows, hips, and knees was limited. Adduction of the hips was not possible and congenital dislocation of the right hip was present. The anal mucosa was extraverted.
Routine laboratory examinations were normal at admission and on subsequent occasions. X rays showed bilateral additional ribs and confirmed the presence of congenital dislocation of the right hip.
The subsequent clinical history included severe and prolonged apnoea crises associated with tongue retroversion and the development of hypoplasia of the right facial skeleton, involving the temporal, maxillary, and frontal bones. Marked asymmetry of the thorax became evident during the third month. She survived to the third year, when she was lost to follow up.
Material and methods
CELL CULTURES AND CHROMOSOME PREPARATIONS PHA stimulated peripheral blood lymphocytes were cultured for 72 hours in RPMI 1640 medium supplemented with 15% FCS. For Epstein-Barr virus (EBV) immortalisation, lymphocytes were separated on a Ficoll-Hypaque gradient and infected with EBV produced by B95-8 marmoset cells.6 For R banding, BrdU (30 jig/ml) was added during the last seven hours in culture before harvesting. For high resolution banding the cells were synchronised with MTX for 16 hours.
Chromosome preparations were performed after a two hour treatment with colcemid (0-03 ,ug/ml) according to the standard procedure, based on hypotonic swelling in KC1 0-075 mol/l and fixation in methanol:acetic acid (3:1).
STAINING AND BANDING
Chromosomes were counted on Giemsa stained metaphases. The karyotypes of the patient and her parents were analysed on QFQ banded mitoses from peripheral blood cultures. GTG, RBG,7 8 dystamicin A/DAPI,9 and NOR bandingl' was performed on the EBV transformed lymphocytes of the patient.
DNA PROBES E5 (courtesy of G N Ranzani) corresponds to the 3' terminal region of the 28S rRNA gene and a portion of the adjacent, non-transcribed spacer; it is a 7 kb BamHI fragment cloned in pUC8.
The MC probes were isolated from a library of EcoRI fragments derived from the sorted MC DNA, cloned into XgtWES/B'."1 12 Single copy DNA probes were selected as plaques non-hybridising to labelled human DNA after two rounds ofhybridisation to plaque lifts of the MC library according to standard protocols.'3 Each of the probes selected identified a single fragment when hybridised to total human DNA restricted with EcoRI. The average size of the inserts was 6-5 kb.'2
PROBE LABELLING AND IN SITU HYBRIDISATION
The probes were labelled by nick translation with a commercial kit (Amersham) using three tritiated nucleotides: 3H-dATP, 3H-dCTP, and 3H-dTTP. The specific activity ranged from 4x 107 to 108 cpm/4tg. The labelled probes were separated from unincorporated precursors on a Sephadex G-50 column, then precipitated with two volumes of ethanol, and resuspended in hybridisation buffer' at concentrations ranging from 50 to 500 ng/ml. The probes were denatured for 10 minutes at 70°C and quick chilled in ice.
In situ hybridisation was performed essentially as previously described.'4 Briefly, slides were treated with RNase (type III, Sigma) at 37°C for one hour and dehydrated through an ethanol series before denaturation in 70% formamide/2 x SSC. After denaturation the slides were placed into cold 2 x SSC and dehydrated through an ethanol series at 4°C. Solutions with different concentrations of the probes were placed onto the slides under a coverslip and hybridised overnight at 42°C. The slides were then washed four times in 50% formamide/2x SSC at 39°C for 10 minutes, three times in 2xSSC at 390C for 10 minutes, three times in 2xSSC at room temperature for 10 minutes, and twice in 0-1 x SSC at room temperature for one hour. Parallel experiments with all the probes derived from the MC library were performed under conditions of higher stringency by increasing the hybridisation temperature to 47°C and raising the formamide of the washes to 52% at 390C.
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Discussion
A combined cytological and molecular approach has been successfully used to establish the origin of an unidentified, small, extra chromosome. The sequential steps included the fluorescence activated sorting of the marker chromosome, the production of a chromosome specific DNA library, the selection of clones corresponding to low copy number sequences, and in situ hybridisation with the isolated DNA probes.
The method is certainly laborious and time consuming, but, under circumstances such as those encountered in the case reported, it is necessary to arrive at the identification of the chromosome. Callen et al16 have recently described a rapid and simple in situ method for the identification of supernumerary markers using probes to chromosome specific pericentric repeats. We did try a similar approach using a 9 specific repetitive DNA probe (QP23, courtesy of M Jeanpierre) in order to characterise the MC better before sorting. A much weaker signal was detected on the MC than on the normal chromosome 9 (data not shown). To account for these results, the occurrence of a deletion in the pericentromeric region of the MC can be postulated. Therefore, the approach suggested by Callen et al'6 was unsuitable for the identification of our MC.
Alternatives to sorting for the isolation of the MC, such as the production of monochromosomic interspecific hybrids17 or pulsed field gel electrophoresis (PFGE), '8 19 were not considered since the production and maintenance of monochromosomic cell hybrids has an extremely low probability in the absence of a selective system, while PFGE has not yet been applied for the isolation of fragments larger than 12 Mb.20 Recent developments in the microdissection of chromosomes2' make it a very promising approach for isolating and cloning sequences directly from the MC, thus avoiding the cloning of non-specific DNA derived from chromosomal debris sorted along with the MC."
With the aid of the DNA library derived from the MC we have been able to restrict the origin of the marker to the region 9pl3-cen where all the probes tested were localised.
To establish a possible correlation between the clinical phenotype of the patient and the presence of the small supernumerary chromosome identified as a number 9 derivative, attention should be given to the presence of a complete mosaic trisomy 9. Though present in a low proportion of cells, this may be sufficient to account for the observed pathological symptoms, such as severe micrognathia, joint luxations, additional ribs, and severe reduction in size of one leg, that are traits associated with mosaic trisomy.22
